title: [Japanese Guidelines for the Management of Stroke 2009 : important revised points necessary for the neurologist].
abstract: The first post-publication external review of the Japanese Guidelines for the Management of Stroke 2004 had been published in "Stroke" in 2009. Considering to these results, new stroke guidelines 2009 has been published in Japan on November 2009. Main renewed and revised points in guidelines 2009, particularly important for the neurologist were introduced, focusing on acute stroke treatment such as administration of t-PA, management of patients with life-style related diseases as well as new antiplatelet therapy for the secondary stroke prevention.
authors.affiliation: Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital.
authors.forename: Yukito
authors.initials: Y
authors.lastname: Shinohara
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D000069059:Atorvastatin; D000077407:Cilostazol; D048909:Diabetes Complications / Q000150:complications / Q000188:drug therapy; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D019317:Evidence-Based Medicine; D006538:Heptanoic Acids / Q000008:administration & dosage; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007564:Japan; D009462:Neurology; D010820:Physicians; D000077205:Pioglitazone; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic / Q000592:standards*; D011758:Pyrroles / Q000008:administration & dosage; D055502:Secondary Prevention; D020521:Stroke / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D013777:Tetrazoles / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D013777:Tetrazoles; D045162:Thiazolidinediones; D000069059:Atorvastatin; D010959:Tissue Plasminogen Activator; D000077407:Cilostazol; D001241:Aspirin; D000077205:Pioglitazone